Depressie en cognitie bij type 2 diabetes. Miranda Schram afdeling Interne Geneeskunde MUMC+

Similar documents
The heat is on (and on)

Nationaal Pijncongres Ing. Maurice Uytdewilligen (Bsc) Directeur APS-Therapy BV

The public health benefits of vaccination: expenditures, morbidity & mortality

Hemodialysis induces an acute decline in cerebral perfusion in elderly patients

The Metabolic Syndrome: Is It A Valid Concept? YES

Vitamin D supplementation of professionally active adults

Total amount and patterns of sedentary behaviour & glucose metabolism status

STATEC. Selective Targeting of Adjuvant Therapy for Endometrial Cancer. Florine Eggink National kick-off meeting April 17th 2018

Luchtvervuiling en gezondheid: de mechanistische inzichten

Diabetes Mellitus: A Cardiovascular Disease

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes

Fructose in diabetes: Friend or Foe. Kim Chong Hwa MD,PhD Sejong general hospital, Division of Endocrinology & Metabolism

Other Ways to Achieve Metabolic Control

Depok-Indonesia STEPS Survey 2003

300 Biomed Environ Sci, 2018; 31(4):

Supplementary Online Content

Brain tissue and white matter lesion volume analysis in diabetes mellitus type 2

Non-insulin treatment in Type 1 DM Sang Yong Kim

Opportunities and challenges for human papillomavirus vaccination in cancer prevention

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

SCIENTIFIC STUDY REPORT

Supplementary Online Content

Epidemiology of Diabetes, Impaired Glucose Homeostasis and Cardiovascular Risk. Eberhard Standl

Informing HPV vaccination strategy about target groups: girls-only, gender-neutral, catch-up and selective adult vaccination

Standards of Medical Care in Diabetes 2016

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES

Guidelines on cardiovascular risk assessment and management

Why is Earlier and More Aggressive Treatment of T2 Diabetes Better?

Shiftwork and cardiometabolic outcomes. Dr Anil Adisesh

The Diabetes Link to Heart Disease

LUNG CANCER EARLY MOLECULAR ASSESSMENT KIM MONKHORST WEEK VAN DE PATHOLOGIE 29 MAART

Heart and Kidney, for better or for worse

De dialysefistel: snel maken, snel staken? Joris Rotmans, internist-nefroloog Afdeling Interne Geneeskunde Leids Universitair Medisch Centrum

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Macrovascular Disease in Diabetes

6/10/2016. Hui-Chun Hsu

Cardiovascular Risk Assessment and Management Making a Difference

Diabetes Prevention. Preventing Diabetes -- On AAA Home, the hyperlink beside the LESS Initiative hyperlink.

Intestinal Stem Cells And Organoids

Pitfalls in chemical burns

Patient is healthy with no chronic disease or significant risk factors [16%].

Standards of Medical Care In Diabetes

Adolescent Bariatric Surgery

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Establishment of Efficacy of Intervention in those with Metabolic Syndrome. Dr Wendy Russell - ILSI Europe Expert Group

Preventing Diabetes K A R O L E. W A T S O N, M D, P H D, F A C C P R O F E S S O R O F M E D I C I N E / C A R D I O L O G Y

programme. The DE-PLAN follow up.

CRP and fibrinogen imply clinical outcome of patients with type-2 diabetes. and coronary artery disease

Cognitive ageing and dementia: The Whitehall II Study

Cardiovascular disease and diabetes Vascular harmony

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?

Energy Balance Equation

Diabetes, Diet and SMI: How can we make a difference?

Targeting Glucose Metabolism to Stop Strokes IRIS: Insulin Resistance In Stroke study

Resting Heart Rate and The Risk Of Developing Impaired Fasting Glucose and Diabetes: The Kailuan Prospective Study

METABOLIC SYNDROME IN REPRODUCTIVE FEMALES

Magnetic resonance imaging, image analysis:visual scoring of white matter

A new look on the renal risks of lithium. Maarten B Rookmaaker

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead

Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease in Individuals With Type 1 Diabetes: A 12-Year Follow-up Study

Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcomes

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES

Community Based Diabetes Prevention

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

Type 2 Diabetes in Adolescents

ENDOTHELIAL PROGENITOR CELLS AS A NOVEL BIOMARKER OF VASCULAR HEALTH

Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

HOW TO DEFINE GOOD BIOMARKERS OF HEALTH? Suzan Wopereis

DIABETES. A growing problem

Baroreflex amplificatie als behandeling voor hypertensie: hype of hoop? Wilko Spiering Afdeling Vasculaire Geneeskunde

Metabolic Syndrome and Workplace Outcome

SMARTool clinical and biohumoral results. Chiara Caselli IFC-CNR

Inflammation and and Heart Heart Disease in Women Inflammation and Heart Disease

Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA)

Clinical Care Performance. Financial Year 2012 to 2018

1/28/2014. The Metabolic Syndrome: Early History. Insulin Resistance: Early Diagnosis and Treatment to Prevent Cardiovascular Disease

Arterial function and longevity Focus on the aorta

The Clinical Unmet need in the patient with Diabetes and ACS

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

Diabetes and Obesity Sex- and Gender-differences!

Low carbohydrate diets- do they have a place?

The Effect of Hypertonicity on Glucose Regulation in Healthy Adults

CVD Prevention, Who to Consider

Diabetes Mellitus: Implications of New Clinical Trials and New Medications

The promise of the thiazolidinediones in the management of type 2 diabetes-associated cardiovascular disease

Analytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health

surtout qui n est PAS à risque?

Diabetes type-2 patients can stop insulin treatment when following the low carbohydrate lifestyle

Regional differences of macrovascular disease in Northeast and South Germany: the population-based SHIP-TREND and KORA-F4 studies

Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study

Identification of subjects at high risk for cardiovascular disease

Diabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology

Diabetic Retinopathy: a case study David Garland NP

Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions

University of Groningen. Metabolic risk in people with psychotic disorders Bruins, Jojanneke

Transcription:

Depressie en cognitie bij type 2 diabetes Miranda Schram afdeling Interne Geneeskunde MUMC+

Disclosure potential conflicts of interest Geen (potentiële) belangenverstrengeling Voor bijeenkomst mogelijk relevante relaties: Bedrijfsnamen Sponsoring of onderzoeksgeld - Honorarium of andere (financiële) vergoeding - Aandeelhouder - Andere relatie, namelijk -

Eén derde van de volwassen Limburgers heeft (pre)diabetes 2 van 6 vakken met publiek

Type 2 diabetes and depression Risk of depression in type 2 diabetes is doubled QoL, societal costs Mortality risk : OR for mortality 1.46 * OR for cvd mortality 1.39 * * F. van Dooren et al, Plos One 2013; 8(3):e57058

Course of depression in type 2 diabetes

Course of depression in type 2 diabetes Paucity of data Probably a chronic course Under reported, under recognised, under treatment Treatment resistance, ineffective treatment? Different etiology than early life depression Biology largely unknown

Mechanisms Psychosocial variables Lifestyle factors Biological mechanisms

Mechanisms Psychosocial variables Lifestyle factors Biological mechanisms

Mechanisms Psychosocial variables Inflammation Lifestyle factors Biological mechanisms Endothelial dysfunction

Research questions We investigated the associations between markers of - Hyperglycemia (glucose, AGEs) - Inflammation, and - Endothelial dysfunction with depressive symptoms and depressive disorder in a population-based study

Mechanisms Psychosocial variables Inflammation Lifestyle factors Biological mechanisms Endothelial dysfunction

The Maastricht Study 10,000 participants, 40-75 years From the Maastricht area Oversampling of type 2 diabetes Advanced deep phenotyping Survey I: 2010-2018 Dataset n~3400 (Nov 10-Sept 13) Eur J Epidemiology (2014) 29:439-451

Extremely detailed phenotyping

Depression PHQ-9, MINI diagnostic interview (gold standard) Diabetes Oral glucose tolerance test Methods Glycemic control (fasting gluc, HbA1c, AGEs: SAF, Pentosidine, CEL, CML) Inflammation (hscrp, SAA, sicam-1, IL-6, IL-8, TNF-α) Endothelial function (svcam-1, sicam-1, se-selectin, vwf) MRI (brain atrophy and cerebral small vessel disease) Lifestyle (physical activity, sedentary time, nutrition)

General characteristics No type 2 diabetes (n=2349) Type 2 diabetes (n=918) Age, years 58.7 ± 8.2 62.6 ± 7.6 Female sex, n (%) 1291 (55%) 298 (33%) Partner, n (%) 1972 (85%) 731 (82%) Educational level, % low/middle/high 28/28/44 46/28/26 HbA1c, % 5.5 ± 0.4 6.9 ± 1.0 Smoking, % never/former/current 37/50/12 28/56/16 Body mass index, kg/m 2 26.0 ± 3.9 29.9 ± 5.0 Blood pressure, mmhg 132 ± 17 / 76 ± 10 142 ± 18 / 77 ± 10 Total cholesterol, mmol/l 5.5 ± 1.1 4.5 ± 1.0 HDL cholesterol, mmol/l 1.61 ± 0.47 1.27 ± 0.37 N= 3267

Prevalence of depression prevalence in % 10 9 8 7 6 5 4 3 2 3,4 * 6,2 * 2,7 2,7 * 6,3 4,0 * 9,0 Non-DM DM2 1 0 1,4 PHQ-9 score > 10 Minor depression Major depression Major and minor depression

Association of depression with T2DM Depressive symptoms Odds ratio 95% CI p-value PHQ-9 score (continuous) 1.06 (1.02-1.09) < 0.001 PHQ-9 10 1.94 (1.20-3.13) 0.007 Depressive disorder Minor depressive disorder (MINI) 1.81 (0.90-3.64) 0.097 Major depressive disorder (MINI) 1.99 (1.24-3.19) 0.005 Adjusted for age, sex, educational level, bmi, smoking, partner status, systolic blood pressure, prior CVD, total cholesterol and HDL cholesterol

Hyperglycemia and depression Independent variables Fasting glucose per SD HbA1c per SD Skin Autofluoresence per SD Hyperglycemia sum score per SD Major depression OR (95%CI) P-value 1.30 (1.09-1.55) 0.003 1.37 (1.15-1.63) 0.001 1.28 (1.02-1.62) 0.036 1.54 (1.22-1.96) <0.001 adjusted for age, sex, smoking, alcohol consumption, hypertension, cholesterol ratio, physical activity, and BMI

Advanced Glycation Endproducts (AGEs) * Adjusted for age, sex, type 2 diabetes, bmi, smoking, egfr Van Dooren et al, Depression and Anxiety, 2016 Jun 6

Insuline resistance and depression Independent variables Major depression OR (95%CI) P-value Fasting insulin per SD HOMA per SD Insulin resistance markers sum score per SD 0.97 (0.8-1.18) 0.740 1.04 (0.83-1.29) 0.756 1.01 (0.78-1.13) 0.923 adjusted for age, sex, smoking, alcohol consumption, hypertension, cholesterol ratio, physical activity, and BMI

Hyperglycemia, IR and depression

Conclusie Type 2 diabetes is geassocieerd met meer depressie Verschillende maten van hyperglycemie zijn geassocieerd met depressie Insuline resistentie is niet geassocieerd met depressie

Mechanisms Psychosocial variables Inflammation Lifestyle factors Biological mechanisms Endothelial dysfunction

Depression PHQ-9, MINI diagnostic interview (gold standard) Diabetes Oral glucose tolerance test Methods Glycemic control (fasting gluc, HbA1c, AGEs: SAF, Pentosidine, CEL, CML) Inflammation (hscrp, SAA, sicam-1, IL-6, IL-8, TNF-α) Endothelial function (svcam-1, sicam-1, se-selectin, vwf) MRI (brain atrophy and cerebral small vessel disease) Lifestyle (physical activity, sedentary time, nutrition)

Low grade inflammation * * * * * OR was 1,54 (1,18-2,02) for LGI sumscore after adjustment for age, sex, DM2, egfr, prior CVD Van Dooren et al, Brain Behaviour and Immunity, 2016 Aug;56:390-6.

Endothelial dysfunction Odds ratio 1,8 1,7 1,6 1,5 1,4 1,3 1,2 1,1 1 Endothelial function is associated with depressive disorder * 1,25 * * 1,35 1,36 1,19 1,64 svcam-1 sicam-1 E-selectine vwf ED sumscore * OR was 1,40 (1,10-1,77) for ED sumscore after adjustment for age, sex, DM2, egfr, prior CVD Van Dooren et al, Brain Behaviour and Immunity, 2016 Aug;56:390-6.

Inflammation and incident depression Longitudinal associations of low-grade inflammation sum score with incident depression Odds ratio 95% CI p value Model 1: crude + demographics 1.81 1.37-2.38 <0.001 Model 2: model 1 + cardiovascular risk factors Model 3: model 2 + lifestyle risk factors 1.44 1.05-1.97 0.022 1.34 0.95-1.88 0.096 Model 1 included age, sex, education status and partner status; model 2 additionally incorporated cardiovascular risk factors as type 2 diabetes status, history of cardiovascular disorder, kidney function and HbA1c; model 3 added modifiable lifestyle risk factors as body mass index (BMI), blood pressure, smoking and physical activity.

Endothelial dysfunction and incident depression Longitudinal associations of endothelial dysfunction sum score with incident depression Odds ratio 95% CI p value Model 1: crude + demographics 1.80 1.43-2.26 <0.001 Model 2: model 1 + cardiovascular risk factors 1.48 1.14-1.92 0.004 Model 3: model 2 + lifestyle risk factors 1.40 1.07-1.84 0.014 Model 1 included age, sex, education status and partner status; model 2 additionally incorporated cardiovascular risk factors as type 2 diabetes status, history of cardiovascular disorder, kidney function and HbA1c; model 3 added modifiable lifestyle risk factors as body mass index (BMI), blood pressure, smoking and physical activity.

LGI, ED and incident depression 55% 45%

Inflammation, endothelial dysfunction and chronic depression Remission Resistant or recurrent LGI Odds ratio 95% CI p value Odds ratio 95% CI p value Model 1: demographics 1.75 1.17; 2.62 0.007 2.72 1.89; 3.93 0.000 Model 2: model 1 + cardiovascular risk factors Model 3: model 2 + lifestyle risk factors 1.82 1.17; 2.83 0.008 1.86 1.21; 2.86 0.005 1.62 0.99; 2.69 0.057 1.69 1.03; 2.77 0.039 ED Model 1: demographics 1.06 0.67; 1.68 0.818 2.18 1.59; 3.00 0.000 Model 2: model 1 + cardiovascular risk factors Model 3: model 2 + lifestyle risk factors 1.01 0.61; 1.67 0.967 1.51 1.04; 2.21 0.032 0.74 0.42; 1.31 0.302 1.37 0.89; 2.09 0.150 Model 1 included age, sex, education status and partner status; model 2 additionally incorporated cardiovascular risk factors as type 2 diabetes status, history of cardiovascular disorder, kidney function and HbA1c; model 3 added modifiable lifestyle risk factors as body mass index (BMI), blood pressure, smoking and physical activity.

Depressie als gevolg van vaatschade ORs = 1.14 1.58 Agtmaal et al JAMA Psychiatry 2017 Jul 1;74(7):729-739.

Conclusie Inflammatie en endotheel dysfunctie zijn geassocieerd met incidente depressie, mogelijk causaal verband Inflammatie en endotheel dysfunctie samen kunnen chronische depressie voorspellen

Mechanisms Psychosocial variables Inflammation Lifestyle factors Biological mechanisms Endothelial dysfunction

Type 2 diabetes and dementia 2x greater risk of dementia in type 2 diabetes Via hyperglycaemia? Via vascular brain damage?

Type 2 diabetes and cognitieve functie

White matter hyperintensities

Brain tissue volumes

Vaatschade in het brein Vaatschade op MRI Geen diabetes Pre-diabetes Diabetes Van Agtmaal et al, submitted

White matter volume Geen diabetes Pre-diabetes Diabetes Van Agtmaal et al, submitted

Grey matter volume Geen diabetes Pre-diabetes Diabetes Van Agtmaal et al, submitted

Cerebrospinal fluid Geen diabetes Pre-diabetes Diabetes Van Agtmaal et al, submitted

Conclusion Prediabetes is associated with White matter hyperintensities Lower white matter volume 4 years of aging T2DM is associated with White matter hyperintensities Lower white matter volume Higher CSF volume 8.5 years of aging

Take home message Depressie en dementie komen 2x zo veel voor bij type 2 diabetes Verklarende mechanismen hiervoor zijn: Hyperglycemie Inflammatie Endotheel dysfunctie Vasculaire brein schade Zowel prediabetes als type 2 diabetes zijn geassocieerd met versnelde veroudering van het brein weefsel vergelijkbaar met 4 vs 8 jaar veroudering

Eén derde van de volwassen Limburgers heeft (pre)diabetes 2 van 6 vakken met publiek

17 PhD theses on The Maastricht Study A further 20 PhD theses in preparation